EX-10.1 2 d458746dex101.htm EX-10.1 EXECUTION VERSION TERMINATION AGREEMENTTermination Agreement • May 5th, 2020 • New York
Contract Type FiledMay 5th, 2020 JurisdictionTHIS TERMINATION AGREEMENT (this “Termination Agreement”) is made and entered into effective as of the Termination Effective Date by and between IMMUNOMEDICS, INC., a Delaware corporation (“IMMU”), and SEATTLE GENETICS, INC., a Delaware corporation (“SGEN”). Each of IMMU and SGEN may be referenced herein individually as a “Party”and collectively as the “Parties”.
TERMINATION AGREEMENTTermination Agreement • September 18th, 2017 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 18th, 2017 Company Industry JurisdictionTHIS TERMINATION AGREEMENT (this “Termination Agreement”) is made and entered into effective as of the Termination Effective Date by and between IMMUNOMEDICS, INC., a Delaware corporation (“IMMU”), and SEATTLE GENETICS, INC., a Delaware corporation (“SGEN”). Each of IMMU and SGEN may be referenced herein individually as a “Party” and collectively as the “Parties”.
TERMINATION AGREEMENTTermination Agreement • September 15th, 2017 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 15th, 2017 Company Industry JurisdictionTHIS TERMINATION AGREEMENT (this “Termination Agreement”) is made and entered into effective as of the Termination Effective Date by and between IMMUNOMEDICS, INC., a Delaware corporation (“IMMU”), and SEATTLE GENETICS, INC., a Delaware corporation (“SGEN”). Each of IMMU and SGEN may be referenced herein individually as a “Party”and collectively as the “Parties”.